Literature DB >> 19406986

NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses.

Philippe Krebs1, Michael J Barnes, Kristin Lampe, Karen Whitley, Keith S Bahjat, Bruce Beutler, Edith Janssen, Kasper Hoebe.   

Abstract

Previous work showed that administration of antigen-expressing apoptotic cells in vivo results in antigen-specific CD8+ T-cell responses independent of Toll-like receptor signaling. We report here that natural killer (NK) cells can serve a function directly upstream of this pathway and initiate robust adaptive immune responses via killing of antigen-expressing target cells. This pathway is highly sensitive, in that administration of as few as 10(4) target cells induced detectable antigen-specific CD8+ T-cell responses. Importantly, NK cell-mediated cytotoxicity of target cells could also induce robust antigen-specific CD4+ T-cell responses, which were critical for subsequent CD8+ T-cell priming and IgG responses. Unlike adaptive immune responses induced by gamma-irradiated cells, the NK-cell pathway required myeloid differentiating factor 88 (MyD88) and Toll/interleukin-1 receptor domain-containing adapter-inducing interferon-beta (Trif) signaling. NK cells have previously been shown to detect and kill pathogen-infected host cells, as well as neoplastic cells and tissue allografts. The present data provide further evidence that they also discharge a strong tie with their relatives in the adaptive immune system. We think that the recognition and killing of target cells by NK cells represents an important pathway for the generation of robust CD8+ T and humoral responses that may be exploited for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406986      PMCID: PMC2710917          DOI: 10.1182/blood-2009-01-201467

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses.

Authors:  Ralph Mocikat; Heidi Braumüller; Alain Gumy; Oliver Egeter; Heike Ziegler; Uwe Reusch; Anja Bubeck; Jacques Louis; Reinhard Mailhammer; Gert Riethmüller; Ulrich Koszinowski; Martin Röcken
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

2.  Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.

Authors:  Jennifer A Westwood; Janice M Kelly; Jane E Tanner; Michael H Kershaw; Mark J Smyth; Yoshihiro Hayakawa
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 3.  In search of the 'missing self': MHC molecules and NK cell recognition.

Authors:  H G Ljunggren; K Kärre
Journal:  Immunol Today       Date:  1990-07

4.  Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming.

Authors:  Hélène Jusforgues-Saklani; Martin Uhl; Nathalie Blachère; Fabrice Lemaître; Olivier Lantz; Philippe Bousso; Deborah Braun; James J Moon; Matthew L Albert
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

5.  The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes.

Authors:  S Fossum; B Rolstad
Journal:  Eur J Immunol       Date:  1986-04       Impact factor: 5.532

6.  Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.

Authors:  C H Ladel; I E Flesch; J Arnoldi; S H Kaufmann
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

7.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

Review 8.  The role of inflammation in tumour growth and tumour suppression.

Authors:  Thomas Blankenstein
Journal:  Novartis Found Symp       Date:  2004

9.  Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways.

Authors:  Kasper Hoebe; Edith M Janssen; Sung O Kim; Lena Alexopoulou; Richard A Flavell; Jiahuai Han; Bruce Beutler
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.

Authors:  H I Levitsky; A Lazenby; R J Hayashi; D M Pardoll
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  56 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  Yet another role for natural killer cells: cytotoxicity in immune regulation and viral persistence.

Authors:  Christine A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-31       Impact factor: 11.205

Review 4.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

5.  How host defense is encoded in the mammalian genome.

Authors:  Bruce Beutler; Christopher C Goodnow
Journal:  Mamm Genome       Date:  2010-12-25       Impact factor: 2.957

Review 6.  Natural killer cells in human autoimmune diseases.

Authors:  Nicolas Schleinitz; Frédéric Vély; Jean-Robert Harlé; Eric Vivier
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

7.  Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.

Authors:  Ren Zhu; Maryline Mancini-Bourgine; Xiao Ming Zhang; Florence Bayard; Qiang Deng; Marie-Louise Michel
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

8.  An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.

Authors:  Michael Berger; Philippe Krebs; Karine Crozat; Xiaohong Li; Ben A Croker; Owen M Siggs; Daniel Popkin; Xin Du; Brian R Lawson; Argyrios N Theofilopoulos; Yu Xia; Kevin Khovananth; Eva Marie Moresco; Takashi Satoh; Osamu Takeuchi; Shizuo Akira; Bruce Beutler
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

9.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

10.  Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination.

Authors:  Daniel Scott-Algara; Maryline Mancini-Bourgine; Hélène Fontaine; Stanislas Pol; Marie-Louise Michel
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.